[1]
Pawan Trivedi & Priyanka Singh 2021. Is a Five Marker Panel with Basal Marker Expression (EGFR and/or CK5/6) Superior to a Three Marker Panel in Predicting Prognosis in Molecular Subtypes of Breast Carcinoma? A Comparative Study. Recent Developments in Medicine and Medical Research Vol. 11. (Oct. 2021), 7–16. DOI:https://doi.org/10.9734/bpi/rdmmr/v11/14345D.